1. MB BCh: with honor degree April 1982 El-Mansoura Faculty of medicine, El-Mansoura University.
2. M.SC: Internal medicine Nov. 1986 El-Mansoura University.
3. MD: Internal medicine Nov.1991.
4. Associate Professor of Internal Medicine, El-Mansoura University 1997.
5. Prof. of Medicine, March 2002.

• Resident at internal medicine Dept, El-Mansoura University hospital from Sep.1983 - Jan 87 with training on G.I.endoscopy.
• Training for 6 months 1-1-1987, 30-6-1987 at El-Mansoura Nephrology institute on dialysis for chronic renal failure.
• Endoscopic training in the military Academy, Cairo11-1-1989 till 18-3-1989.
• Advanced training on Gastro intestinal endoscopy, Cairo University from 1-4-1989 till 1-10-1989.
• Gastro intestinal Endoscopic training in G.I unit at the Soviet academy of science, Moscow, 26-4-1993 till 30-5-1993.
• Gastro intestinal Endoscopy training in Manchester University for 6 weeks 1993.

1. Egyptian Society of Hepatology (member of the board).
2. Egyptian Gastrointestinal endoscopic society (member of the board).
3. British Society of Gastroenterology (BSG) since 1994.
4. European Association for the study of liver diseases (EASL).
5. American Association for the Study of Liver Diseases (AASLD).
6. Asian Pacific Association for the study of liver diseases 2004.
7. The Egyptian Society of Hepatology, Gastroenterology and Infectious Diseases 2004.
   

• Local Hepatology and G.I. Meetings in Egypt.
• International conference. A research and clinical update of Infectious diseases and public health, Alexandria, October 1997.
• 10th World congress OF digestive endoscopy. International council of surgical Gastroenterology, Bangkok, February 2002.
• The 5th Sino-Egyptian symposium on Hepatology Beijing, August 2004
• 3rd JSH topic conference " Nonalcholic steatohepatits in Asia Oceania Kochi, October 2004.
• Video - Digest International, November 2004.
• Interactive Expert Panel. Hepatitis C virus; hematological complications of therapy and therapy of complications, June 2005.

International conferences:

Participate in many international meetings since 1993 by either oral or poster presentations, including the annual meetings of European Association for the study of liver diseases (EASL), European Union Gastroenterology week (EUGW), American Association for the study of liver diseases (AASLD) and British society of gastro (BSG).

1. Young investigator award United European Gastroenterology meeting Oslo 1994.
2. Research award tenth Asian Pacific congress of Gastro- enterology, Yokohama 1996.
3. Best poster award BSG, Glasgow 1999.
4. Best oral presentation Egyptian Hepatology meeting Nov.2000.
5. Research award, Mansoura University 1993.
6. Award of Japan society of Hepatology, October 2004.

1. G.Shiha, S.Salem et al., Gastric variceal ligation : Anew technique , Gastrointestinal Endoscopy, volume 49, No.4, part 1, 1999.
2. G.Shiha, Kh.Zalata et al., Does Schistosomasis interferer with application of knodell score for assessment of chronic hepatitis-C, Medical Science Monitor, 8 (2) 72-77, 2002.
3. G.Shiha, AbdElFatah Attallah, M.Shahat, W.Samir, Adel Tabel et al., Clinical significance of detection and Arab Journal of Gastrology genotyping of hepatitis-C virus among Egyptian patients using PCR , Vol.1, No.2,Oct. 2000 p 187-193.
4. G.Shiha, M.Hamed, H.ElAskalany, Ayman Menesy, S.Salem et al., Mononitrates and combination of mononitrates and propranolol as adjuvant to sclerotherapy for the prevention of rebleeding from esophageal varices, Digestion, 1998 , 59(suppl.31), 1-820 Abstract No. FoLM2512.
5. G.Shiha, H alasklani, Kh zalata, Elham Abd alsameia, S.Salem, et al., A comparative study of interferon-?2b with and without ribavirin for the treatment of chronic hepatitis C genotype IV., Mansoura Medical Journal, Vol. 32, No.3, 4 Jan & April, 2001.
6. G.Shiha, H alasklani, E.alsyed, S.Salem, et al., Identification of risk factors for early rebleeding from oesophago-gastric varices: A prospective study., Mansoura Medical Journal, Vol. 32, No.3, 4 Jan & April, 2000.
7. G.Shiha, S.Salem et al., Sclerotherapy versus Variceal ligation with a multiband device in the control of acute bleeding from esophageal varices: A prospective randomized study, Zagazig University Medical Journal, vol V1, No.5, Sept.2000.
8. G.Shiha, Kh.Zalata, A.Abdalah, Mostafa.M et al., Immunohistochemical identification of HCV target antigen in paraffin embedded liver tissue using the TORDJI-22 antibody: Reproducibility and staining patterns, Liver International (in press)
9. F.M.Farag, G.Shiha, H.ElAskalany, Ayman Menesy et al., Is oesophgeal band ligation superior to injection sclertherapy of varices, Benha Medical Journal Vol, 15, No.3 Set. 1998.
10. S. Salem, G. Shiha, M. Hamed, F. Mohamed, F. Azam. Sclerotherapy versus sclerotherapy and propranolol in the prevention of rebleeding from oesophageal varices: a randomized study. Gut 1996, 38: 770-774.
11. A. Ata, G. Shiha, S El-Morsy G El-Abady Detection of schistosoma circulating antigen before and after praziquantel chemotherapy using fast dot ELISA. Journal of Hepatology, Gfastroenterology and Infectious Diseases 1995; 4:35-43.
12. G. Shiha, M. Hamed, S. Salem, F. Mohamed, H. Askalany. Octerotide infusion plus emergency sclerotherapy versus sclerotherapy alone for the control of bleeding oesophageal varices: A prospective randomized clinical trial. Endoscopy 1996; 28:S35, (Abstract 1066).
13. G. Shiha, I. Dawoad. Denver peritoneo jugular shunt for refractory ascites: predictive factors of treatment success. The Egyptian Journal of Surgery 1996; 15:37-48.
14. G. Shiha, S. Salem, F. Mohamed, M. Hamed, O. El-Baz. Prevalence of hepatitis C in patients with bleeding oesophageal varices: Clinical significance and impact an the outcome of sclerotherapy. Triennial International Symposium on Viral Hepatitis and Liver Diseases 1996, Abstract C 25.
15. Shiha G. Hamed M, Abbas F, Abd Elal A, Khafagy M and ElShinawy F. DR polymorphism in chronic active hepatitis C. Mansoura Medical Journal 1996; 26: No. 1 & 2 Jan and April: 207-223.
16. Fatma E, Magdy H, Atef M, Shiha G, Saher H, Hassan M, Faiza G and Tosson A. Effect of antischistosomal treatment on schistosmal hepatic pathology: An experimental study in Syrian Golden Hamesters. J. Egypt Soc. Parasite, 1996;26 (2): 517-524.
17. Shiha G., Attalah A, Abu El-Maaty M.R.M. amd Mounir B. Response ribavirin in patients with chronic hepatitis C and its relation to HCV genotyping, schistosomiais and disease severity, Benha Medical Journal 1999, Vol. 16 No.3 Sept. P 861- 872.
18. Shiha G., Attalah A,Ismael H, TAbel.A, Eldesouky.I. A Novel Antigen Detection Immunoassay for field Diagnosis of Hepatitis C virus infection. Journal of Immunoassay & immunochemistry Vol.24. No.4 PP.395-407, 2003.
19. Shiha G., Zalta. K, AbdAllah.A, Mohamed.M. Utility of a novel HCV-NS4 antigen detection immunoassay for monitoring treatment of HCV- infected individuals with pegylated interferon ?-2a. Hepatology Research 2004.
20. Shiha G., AbdAllah.A, Camelia A, Abdel Malak, Nabih A, Elghawalby, Ahmed S Shehatta, Mohamed Abdel-Raouf . Identification of a specific Marker for hepatitis C virus infection using capillary Zone electrophoresis. Clinical chemica Acta (236) 171-179 2004.
    

Founder and head of the society of care for the liver patient in Dakahlia since 1995, which has the following activities:

1. Care of the liver patients especially not able.
2. Patient awareness campaign for prevention of viral hepatitis.
3. Establishment of liver research institute.
   

Copyleft © Communications & Information Technology Center , Mansoura University